Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:
Net Sales at Rs 87.47 crore in June 2023 down 20.12% from Rs. 109.49 crore in June 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 9.54 crore in June 2023 down 417.44% from Rs. 3.00 crore in June 2022.
EBITDA stands negative at Rs. 3.45 crore in June 2023 down 133.24% from Rs. 10.38 crore in June 2022.
Mangalam Drugs shares closed at 109.15 on August 10, 2023 (NSE) and has given -7.66% returns over the last 6 months and -26.67% over the last 12 months.
Story continues below Advertisement
| Mangalam Drugs & Organics | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'23 | Mar'23 | Jun'22 | | Net Sales/Income from operations | 87.00 | 90.27 | 109.47 | | Other Operating Income | 0.46 | 0.84 | 0.03 | | Total Income From Operations | 87.47 | 91.11 | 109.49 | | EXPENDITURE | | Consumption of Raw Materials | 59.66 | 55.03 | 82.17 | | Purchase of Traded Goods | 0.00 | 0.93 | 1.01 | | Increase/Decrease in Stocks | 6.21 | 14.97 | -9.25 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.89 | 6.29 | 9.36 | | Depreciation | 3.42 | 2.75 | 2.60 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 16.19 | 13.65 | 15.83 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.89 | -2.51 | 7.78 | | Other Income | 0.02 | 0.29 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -6.87 | -2.21 | 7.78 | | Interest | 3.41 | 3.43 | 3.54 | | P/L Before Exceptional Items & Tax | -10.29 | -5.65 | 4.24 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -10.29 | -5.65 | 4.24 | | Tax | -0.75 | -1.26 | 1.23 | | P/L After Tax from Ordinary Activities | -9.54 | -4.39 | 3.00 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -9.54 | -4.39 | 3.00 | | Equity Share Capital | 15.83 | 15.83 | 15.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -6.02 | -2.77 | 1.92 | | Diluted EPS | -6.02 | -2.77 | 1.92 | | EPS After Extra Ordinary | | Basic EPS | -6.02 | -2.77 | 1.92 | | Diluted EPS | -6.02 | -2.77 | 1.92 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
